ATE267399T1 - Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa) - Google Patents

Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)

Info

Publication number
ATE267399T1
ATE267399T1 AT97117672T AT97117672T ATE267399T1 AT E267399 T1 ATE267399 T1 AT E267399T1 AT 97117672 T AT97117672 T AT 97117672T AT 97117672 T AT97117672 T AT 97117672T AT E267399 T1 ATE267399 T1 AT E267399T1
Authority
AT
Austria
Prior art keywords
fpsa
antibody
cpsa
specific
prostate
Prior art date
Application number
AT97117672T
Other languages
English (en)
Inventor
William Jeffrey Allard
Kwok K Yeung
Zeqi Zhou
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE267399(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/903,750 external-priority patent/US5840501A/en
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE267399T1 publication Critical patent/ATE267399T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
AT97117672T 1996-10-25 1997-10-13 Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa) ATE267399T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73838396A 1996-10-25 1996-10-25
US83496997A 1997-04-07 1997-04-07
US08/903,750 US5840501A (en) 1996-10-25 1997-07-31 Determination of cPSA

Publications (1)

Publication Number Publication Date
ATE267399T1 true ATE267399T1 (de) 2004-06-15

Family

ID=27419236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97117672T ATE267399T1 (de) 1996-10-25 1997-10-13 Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)

Country Status (14)

Country Link
US (2) US5928878A (de)
EP (1) EP0838680B1 (de)
JP (1) JP4274330B2 (de)
AT (1) ATE267399T1 (de)
AU (1) AU746345B2 (de)
CA (1) CA2214488C (de)
CZ (1) CZ295854B6 (de)
DE (1) DE69729156T2 (de)
DK (1) DK0838680T3 (de)
ES (1) ES2221006T3 (de)
HU (1) HU221350B1 (de)
IL (1) IL121659A (de)
NO (1) NO974534L (de)
PT (1) PT838680E (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19641560A1 (de) * 1996-10-09 1998-04-16 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
US6562618B1 (en) * 1997-12-25 2003-05-13 Japan Tobacco, Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
CA2311512A1 (en) * 1999-07-24 2001-01-24 Bayer Corporation Reflex method for the detection of prostate cancer
JP3536731B2 (ja) * 1999-07-28 2004-06-14 富士レビオ株式会社 HIV−1p24抗原の免疫測定方法及び試薬
US6569684B2 (en) 2000-01-06 2003-05-27 University Of Central Florida Method of identifying and treating invasive carcinomas
DE60107022T2 (de) 2000-07-24 2005-11-24 Health Research Inc. Verfahren zur Detektion von Prostata-spezifischem Membran-Antigen in Serum
US6379550B1 (en) 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel
WO2002012549A1 (en) * 2000-08-07 2002-02-14 Vanderbilt University Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
EP1320753A2 (de) * 2000-09-25 2003-06-25 Abbott Laboratories Verfahren und kits zur reduzierung von störungen in plasma oder serum enthaltenden proben bei spezifische bindungstests unter verwendung eines grossen polycations
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
AU2003242815A1 (en) * 2002-03-13 2003-09-22 Biomerieux Method for the characterisation of circulating tumour cells stemming from solid cancers
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
US7666981B1 (en) 2002-05-10 2010-02-23 University Of Central Florida Research Foundation, Inc. Inhibitors of prostasin
US7314709B2 (en) * 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
EP1709448B1 (de) * 2004-01-28 2008-10-22 Turun Yliopisto Verbessertes verfahren zur diagnose des akuten koronarsyndroms
US8012694B2 (en) 2006-09-14 2011-09-06 Immutopics, Inc. Assay for the detection of phosphorylated PTH
EP2107377A1 (de) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-Endothelin-1-Spiegel für die Risikobestimmung von tachyarrhthmischen Ereignissen
US20110111526A1 (en) * 2008-04-09 2011-05-12 B.R.A.H.M.S Gmbh Pro-endothelin-1 for the prediction of impaired peak oxygen consumption
US8658164B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US20130116131A1 (en) 2011-11-08 2013-05-09 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8658166B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8632971B2 (en) 2011-11-08 2014-01-21 Caldera Health Limited Methods and materials for determining the efficacy of prostate cancer therapies
JP6604081B2 (ja) * 2014-08-13 2019-11-13 東ソー株式会社 N型糖鎖が付加している膵臓リボヌクレアーゼ1の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0690203B2 (ja) * 1985-08-23 1994-11-14 中外製薬株式会社 前立腺特異抗原とα▲下1▼−アンチトリプシン複合体の定量方法
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
EP0635575A1 (de) * 1993-07-22 1995-01-25 Wallac Oy Monoklonale Antikörper gegen Epitope in freiem uber nicht in Alpha-1-antichymotrypsin komplexiertem Prostata spezifisches Antigen
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5698402A (en) * 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5710007A (en) * 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
NO974534L (no) 1998-04-27
AU3926797A (en) 1998-04-30
CA2214488C (en) 2007-06-19
DE69729156T2 (de) 2005-05-25
CZ335797A3 (cs) 1998-05-13
DE69729156D1 (de) 2004-06-24
CZ295854B6 (cs) 2005-11-16
ES2221006T3 (es) 2004-12-16
DK0838680T3 (da) 2004-09-27
IL121659A (en) 2000-07-16
AU746345B2 (en) 2002-04-18
EP0838680A1 (de) 1998-04-29
US6107049A (en) 2000-08-22
PT838680E (pt) 2004-08-31
US5928878A (en) 1999-07-27
JPH10177027A (ja) 1998-06-30
HUP9701717A2 (hu) 1998-05-28
JP4274330B2 (ja) 2009-06-03
HU9701717D0 (en) 1997-12-29
NO974534D0 (no) 1997-10-01
HU221350B1 (en) 2002-09-28
IL121659A0 (en) 1998-02-22
EP0838680B1 (de) 2004-05-19
HUP9701717A3 (en) 2000-04-28
CA2214488A1 (en) 1998-04-25

Similar Documents

Publication Publication Date Title
ATE267399T1 (de) Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)
CY1115366T1 (el) Δεικτες ογκου
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
ATE328278T1 (de) Sammelapparat für einschrittigen test von mundflüssigkeiten
RU2003133925A (ru) Способ дифференциальной диагностики деменции альцгеймера и устройство для его проведения
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE69941627D1 (de) Für krebs
ATE78601T1 (de) Test fuer menschlichen brustkrebs.
US5994085A (en) Methods and devices for detecting non-complexed prostate specific antigen
NZ335535A (en) Immunohistochemical assay for carcinoma proliferative status by detecting presence of NGAL protein
DE69811157T2 (de) Immunoassay zur Bestimmung von PSA-ACT
DE50304756D1 (de) Verfaren zur diagnose von neoplasmen
ATE322687T1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1
DK1200826T3 (da) Immunoassay og testanordning med integreret reference
JP2005524380A (ja) 敗血症状態の発症および存在を決定するための装置及び方法
FI104219B1 (fi) Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi
Christofidis Scientific background of the project
Christofidis Scientific background of the project [Radioimmunometric assay for Prostate Specific Antigen (PSA) measurement]
ITMI962054A1 (it) Saggio per la determinazione di anticorpi anti-endomisio

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0838680

Country of ref document: EP

REN Ceased due to non-payment of the annual fee